The Recognition Award program has been established by the Association as a means of recognizing the commitment, achievement and/or potential of individuals in the field of
Clinical Mass Spectrometry. This program is one of the means by which the Association encourages the advancement of mass spectrometry in clinical chemistry via the promotion
of research, education and application.
The MSACL Distinguished Contribution Award
In Recognition of Achievements Made
in the Field of Clinical Mass
Spectrometry that have Furthered
the Advancement of Knowledge
and the Implementation
of Science for the
Benefit of Humanity
Representative Award Medal
Composition: 0.925 silver
Make a Nomination
Self-nominations are not recognized for consideration.
The purpose of the Distinguished Contribution Award is to recognize a contributor who has conducted research, teaching or application of Mass Spectrometry in Clinical
Chemistry of significant impact.
Nominations will be evaluated on elements of the following criteria:
- Program of research: Quality, scope and overall impact on the profession,
- The extent to which the contribution is based on original concepts and/or innovative practices recognized throughout the field over a sustained period,
- The impact the contribution has had on the field, including education, influence on practitioners and the care of patients, organizations, thought leaders, and research,
- Influence on research advancement and career development within the profession
Nominations required only a brief summary of the reason for the nomination. You may be contacted for further details during the decision process.
The Award recognizes a focused or singular achievement in education, technology development or applied mass spectrometry in clinical chemistry. The award is conferred at the MSACL
2015 US: David Millington
Tandem Mass Spectrometry in Clinical Diagnostics, Newborn Screening and Targeted Metabolomics
2015 EU: Linda Thienpont
Mass Spectrometry as Metrological Anchor in Laboratory Medicine – a Meandering River
2016 US: Kenneth Setchell
What We Can Learn from a Drop of Urine – Metabolomics at It's Earliest: Discoveries of Bile Acid Synthesis Disorders, a New Category of Fatal Metabolic Liver Disease and
Development of a Treatment
2017 US: Catherine Feneslau
Rapid Characterization of Microorganisms by Mass Spectrometry: What can be Learned and How?
2017 EU: Isabelle Fournier
Laser-based Mass Spectrometry in Clinics: Changing the Paradigm of Molecular Diagnosis
2018 US: Richard Yost
The Triple Quadrupole: Innovation, Serendipity and Persistence
2018 EU: Cedric Shackleton
Mass Spectrometry and the Elucidation of Steroid Metabolome
The MSACL 2019 EU nomination deadline is April 1, 2019.
Award winner will receive notification by May 2019. The award winner will be recognized during the MSACL 2019 EU